Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Upper Limb Exosuit for Clinic Assistance

3 de novembro de 2021 atualizado por: Tan Tock Seng Hospital

Smart Rehabilitation Exosuits for Clinic and Home Assistance

Aim is to do a feasibility and refinement trial to assess the safety and comfort of the robotic device and their preliminary effect on muscular activity during the performance of activities of daily living.

The study was carried out with 10 stroke participants who had to carry out a series of 10 functional tasks with and without the suit over 3 sessions.

The results are encouraging and show the potential of using wearable robotic devices in a clinical setting.

Visão geral do estudo

Status

Concluído

Condições

Descrição detalhada

Each participant completed 3 ninety-minute long sessions at CART over the course of a week. All participants were closely supervised by 1 occupational therapist and 1 engineer involved in the development of the devices. In the first session, screening of the patient was performed, where the patient's demographics and clinical parameters were collected, including the grip strength of the affected hand measured by a hand dynamometer taking the mean of 2 attempts, and MOCA, FMA and MAS scores. Afterwards, a familiarisation phase was conducted, where the participant trialled the robotic devices to understand their mechanisms and learn how to use them. This phase also allowed the researchers to adjust the fitting of the exoskeletons and tuning the control algorithm of the elbow exoskeleton to the biomechanics of each user, in order to achieve best comfort and assistance.

The participants were instructed to perform a series of elbow/finger flexion and extension movements to understand how to control the exoskeletons. The participants also interacted with different objects (cup, cube, ball) to adjust the positioning of the anchor points in the glove to the position the participants felt most comfortable with. Once the optimised fitting of the devices was identified, the obtained parameters were stored, and the configuration of the devices was left unchanged for reuse in the next session.

In the 2 remaining sessions, participants performed a series of 10 functional tasks. The tasks were performed without assistance (NO-EXO condition) and with assistance (EXO condition) of the exoskeletons. The tasks were performed first in the unpowered condition to allow the participants to familiarise themselves with the tasks before performing them with the assistance of the devices.

The participants were instructed to start every attempt at a task from a position marked on the floor, and with their arms fully relaxed. This was to ensure that variability from unknown factors was minimised. The participants then awaited the instruction from the researchers to commence the task, given in the form of a spoken command triggered by the press of a button. The button was pressed again to signal the end of the task, defined by the following in order of priority: 1) participant decided to stop; 2) the participant dropped the object; 3) therapist decided to stop after deciding the participant was experiencing difficulties and further attempts would not contribute to a successful performance of the task; 4) task is successfully completed.

In addition to the performance of functional tasks, the standing horizontal fingertip reaching distance and the elbow ROM were measured using a measuring tape and a goniometer, respectively.

At the end of the 3rd session, the participants were asked to fill up a questionnaire to provide their subjective feedback regarding comfort, ergonomics, ease of use, overall clinical benefit and user satisfaction.

Tipo de estudo

Intervencional

Inscrição (Real)

10

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

      • Singapore, Cingapura, 308433
        • Tan Tock Seng Hospital

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

21 anos a 80 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Patient with motor deficit(s) due to stroke as diagnosed by CT or MRI, who are attending outpatient rehabilitation services at TTSH Rehabilitation Centre and Centre for Advanced Rehabilitation Therapeutics;
  • Patient with first ever clinical stroke (confirmed on brain imaging);
  • Post stroke of at least 3 months with stable neurological status;
  • Age between 21 to 80 years, inclusive;
  • Hemiplegic pattern and shoulder abduction Medical Research Council motor power > 2/5;
  • Able to give and sign informed consent at research site;
  • Montreal Cognitive Assessment >= 22/30.

Exclusion Criteria:

  • Patient with severe cognitive, perceptual (include hemi-neglect), and/or emotional-behavioural issues that preclude participation;
  • Experiencing moderate to severe levels of pain (visual numeric pain rating scale > 5);
  • Has unstable or terminal medical conditions which may affect participation (e.g. unresolved sepsis, postural hypotension, end stage renal failure) or anticipated life expectancy of < 1 year due to malignancy or neurodegenerative disorder;
  • Non-stroke related causes of arm motor impairment;
  • Local factors which may be worsened by arm therapy or device interface: spasticity of MAS > 3, unhealed skin wounds/rashes, shoulder pain visual analog scale > 5/10, active fractures or arthritis or fixed flexion contractures of shoulder, elbow, wrist or fingers incompatible with device interface;
  • Inability to tolerate 90 minutes of therapy session;
  • Pregnancy or breast feeding;
  • Detectable sensory impairment of affected limb---hemianesthesia to sharp pain.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Viabilidade do dispositivo
  • Alocação: N / D
  • Modelo Intervencional: Atribuição de grupo único
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Outro: Refinement and Feasibility Trial

It is intra - individual comparison study

Arm 1: participant wore the custom-made upper limb exosuit and hand exoskeleton to perform the series of tasks Arm 0: participant perform the same tasks without the custom-made upper limb exosuit and hand exoskeleton.

Participants go through 3 90-min sessions in a clinic setting and perform a series of functional tasks adapted from motor activity log and bilateral upper limb tasks with and without the device.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Assessment of the elbow module by self-reported evaluation via questionnaire
Prazo: End of the 3rd session, median duration of 5 days from baseline
Patient self-reported outcome of the ease of use, ranked from 1 to 5, 5 being the easiest and 1 being the least easy.
End of the 3rd session, median duration of 5 days from baseline
Assessment of the hand module by self-reported evaluation via questionnaire
Prazo: End of the 3rd session, median duration of 5 days from baseline
Patient self-reported outcome of the ease of use, ranked from 1 to 5, 5 being the easiest and 1 being the least easy.
End of the 3rd session, median duration of 5 days from baseline
Successful completion of tasks (without intervention)
Prazo: At 2nd session, median time of 2 days from baseline
The success of the tasks without the assistance of the exoskeletons was evaluated by the clinician.
At 2nd session, median time of 2 days from baseline
Successful completion of tasks (with intervention)
Prazo: At 3rd session, median time of 5 days from baseline
The success of the tasks with the assistance of the exoskeletons was evaluated by the clinician.
At 3rd session, median time of 5 days from baseline

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Upper limb angular trajectory (without intervention)
Prazo: Average over the 2nd session, median time of 2 days from baseline
The upper limb angular trajectories while not wearing the exoskeletons were measured via Inertial Measurement Units (IMUs) to investigate changes in movements of the elbow and shoulder joints.
Average over the 2nd session, median time of 2 days from baseline
Upper limb angular trajectory (with intervention)
Prazo: Average over the 3rd session, median time of 5 days from baseline
The upper limb angular trajectories while wearing the exoskeletons were measured via Inertial Measurement Units (IMUs) to investigate changes in movements of the elbow and shoulder joints.
Average over the 3rd session, median time of 5 days from baseline
Muscular synergies (without intervention)
Prazo: Average over the 2nd session, median time of 2 days from baseline
The muscular synergies of the users while not wearing the exoskeletons were measured by calculating Pearson's correlation coefficient between muscles.
Average over the 2nd session, median time of 2 days from baseline
Muscular synergies (with intervention)
Prazo: Average over the 3rd session, median time of 5 days from baseline
The muscular synergies of the users while wearing the exoskeletons were measured by calculating Pearson's correlation coefficient between muscles.
Average over the 3rd session, median time of 5 days from baseline
Muscular effort (without intervention)
Prazo: Average over the 2nd session, median time of 2 days from baseline
The muscular efforts of the users while not wearing the exoskeletons were measured by surface electromyographic sensors (sEMG), and normalised against the maximum voluntary contraction (MVC) value obtained at the beginning of the session.
Average over the 2nd session, median time of 2 days from baseline
Muscular effort (with intervention)
Prazo: Average over the 3rd session, median time of 5 days from baseline
The muscular efforts of the users while wearing the exoskeletons were measured by surface electromyographic sensors (sEMG), and normalised against the maximum voluntary contraction (MVC) value obtained at the beginning of the session.
Average over the 3rd session, median time of 5 days from baseline

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

23 de março de 2020

Conclusão Primária (Real)

31 de outubro de 2020

Conclusão do estudo (Real)

31 de outubro de 2020

Datas de inscrição no estudo

Enviado pela primeira vez

30 de setembro de 2021

Enviado pela primeira vez que atendeu aos critérios de CQ

3 de novembro de 2021

Primeira postagem (Real)

11 de novembro de 2021

Atualizações de registro de estudo

Última Atualização Postada (Real)

11 de novembro de 2021

Última atualização enviada que atendeu aos critérios de controle de qualidade

3 de novembro de 2021

Última verificação

1 de novembro de 2021

Mais Informações

Termos relacionados a este estudo

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever